A detailed history of Moloney Securities Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 10,260 shares of MRNA stock, worth $378,081. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,260
Previous 5,841 75.65%
Holding current value
$378,081
Previous $693,000 1.15%
% of portfolio
0.1%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$63.64 - $125.14 $281,225 - $552,993
4,419 Added 75.65%
10,260 $685,000
Q2 2024

Jul 30, 2024

SELL
$101.21 - $166.61 $476,091 - $783,733
-4,704 Reduced 44.61%
5,841 $693,000
Q1 2024

May 01, 2024

BUY
$85.37 - $115.44 $233,401 - $315,612
2,734 Added 35.0%
10,545 $1.12 Million
Q4 2023

Jan 30, 2024

BUY
$69.51 - $104.43 $128,593 - $193,195
1,850 Added 31.04%
7,811 $776,000
Q3 2023

Oct 31, 2023

SELL
$96.41 - $126.61 $10,894 - $14,306
-113 Reduced 1.86%
5,961 $615,000
Q2 2023

Jul 31, 2023

SELL
$118.5 - $160.53 $460,017 - $623,177
-3,882 Reduced 38.99%
6,074 $737,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $328,704 - $477,379
-2,423 Reduced 19.57%
9,956 $1.53 Million
Q4 2022

Jan 30, 2023

BUY
$118.38 - $210.04 $84,996 - $150,808
718 Added 6.16%
12,379 $2.22 Million
Q3 2022

Oct 31, 2022

BUY
$118.07 - $194.18 $91,504 - $150,489
775 Added 7.12%
11,661 $1.38 Million
Q2 2022

Aug 03, 2022

SELL
$117.13 - $176.59 $521,228 - $785,825
-4,450 Reduced 29.02%
10,886 $1.56 Million
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $248,873 - $462,578
1,968 Added 14.72%
15,336 $2.64 Million
Q4 2021

Jan 28, 2022

BUY
$225.82 - $368.51 $28,227 - $46,063
125 Added 0.94%
13,368 $3.4 Million
Q3 2021

Oct 27, 2021

SELL
$221.9 - $484.47 $1.03 Million - $2.24 Million
-4,620 Reduced 25.86%
13,243 $5.1 Million
Q2 2021

Jul 26, 2021

BUY
$129.91 - $234.98 $958,086 - $1.73 Million
7,375 Added 70.32%
17,863 $4.2 Million
Q1 2021

Apr 28, 2021

BUY
$109.18 - $185.98 $88,981 - $151,573
815 Added 8.43%
10,488 $1.37 Million
Q4 2020

Feb 08, 2021

SELL
$65.74 - $169.86 $27,084 - $69,982
-412 Reduced 4.09%
9,673 $1.01 Million
Q3 2020

Oct 20, 2020

SELL
$54.34 - $94.85 $561,060 - $979,326
-10,325 Reduced 50.59%
10,085 $714,000
Q2 2020

Jul 31, 2020

SELL
$29.67 - $80.0 $449,648 - $1.21 Million
-15,155 Reduced 42.61%
20,410 $1.31 Million
Q1 2020

May 08, 2020

SELL
$17.78 - $31.58 $11,290 - $20,053
-635 Reduced 1.75%
35,565 $1.07 Million
Q4 2019

Feb 06, 2020

SELL
$13.93 - $21.28 $1.43 Million - $2.19 Million
-102,750 Reduced 73.95%
36,200 $708,000
Q3 2019

Nov 01, 2019

BUY
$12.26 - $18.07 $1.03 Million - $1.52 Million
83,875 Added 152.29%
138,950 $2.21 Million
Q2 2019

Jul 29, 2019

BUY
$13.7 - $28.34 $47,086 - $97,404
3,437 Added 6.66%
55,075 $806,000
Q1 2019

May 03, 2019

BUY
$14.45 - $23.7 $746,169 - $1.22 Million
51,638 New
51,638 $1.05 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.